Follow
Andrew P Montgomery
Andrew P Montgomery
Verified email at sydney.edu.au
Title
Cited by
Cited by
Year
Late-stage functionalization for improving drug-like molecular properties
NJ Castellino, AP Montgomery, JJ Danon, M Kassiou
Chemical reviews 123 (13), 8127-8153, 2023
442023
Computational glycobiology: Mechanistic studies of carbohydrate-active enzymes and implication for inhibitor design
AP Montgomery, K Xiao, X Wang, D Skropeta, H Yu
Advances in protein chemistry and structural biology 109, 25-76, 2017
322017
Recent scaffold hopping applications in central nervous system drug discovery
TB Callis, TR Garrett, AP Montgomery, JJ Danon, M Kassiou
Journal of Medicinal Chemistry 65 (20), 13483-13504, 2022
262022
Computational characterisation of the interactions between human ST6Gal I and transition‐state analogue inhibitors: insights for inhibitor design
A Montgomery, R Szabo, D Skropeta, H Yu
Journal of Molecular Recognition 29 (5), 210-222, 2016
232016
Transition state-based ST6Gal I inhibitors: Mimicking the phosphodiester linkage with a triazole or carbamate through an enthalpy-entropy compensation
AP Montgomery, D Skropeta, H Yu
Scientific Reports 7 (1), 14428, 2017
202017
DYRK1A negatively regulates CDK5-SOX2 pathway and self-renewal of glioblastoma stem cells
B Chen, D McCuaig-Walton, S Tan, AP Montgomery, BW Day, M Kassiou, ...
International journal of molecular sciences 22 (8), 4011, 2021
182021
Design, synthesis and evaluation of carbamate-linked uridyl-based inhibitors of human ST6Gal I
AP Montgomery, C Dobie, R Szabo, L Hallam, M Ranson, H Yu, ...
Bioorganic & Medicinal Chemistry 28 (14), 115561, 2020
172020
An update on late-stage functionalization in today’s drug discovery
AP Montgomery, JM Joyce, JJ Danon, M Kassiou
Expert Opinion on Drug Discovery 18 (6), 597-613, 2023
102023
Computer‐aided design of human sialyltransferase inhibitors of hST8Sia III
C Dobie, AP Montgomery, R Szabo, D Skropeta, H Yu
Journal of Molecular Recognition 31 (2), e2684, 2018
102018
Sialyltransferase Inhibitors as Potential Anti-Cancer Agents
D Skropeta, C Dobie, AP Montgomery, H Steele, R Szabo, H Yu
Australian Journal of Chemistry 74 (11), 758-766, 2021
52021
The discovery of a potent and selective pyrazolo-[2, 3-e]-[1, 2, 4]-triazine cannabinoid type 2 receptor agonist
M Moir, S Lane, AP Montgomery, D Hibbs, M Connor, M Kassiou
European Journal of Medicinal Chemistry 210, 113087, 2021
52021
Tricyclic heterocycles display diverse sensitivity to the A147T TSPO polymorphism
R Sokias, EL Werry, HWA Cheng, JH Lloyd, G Sohler, JJ Danon, ...
European Journal of Medicinal Chemistry 207, 112725, 2020
52020
Synthesis and evaluation of various heteroaromatic benzamides as analogues of–ylidene-benzamide cannabinoid type 2 receptor agonists
M Moir, R Boyd, H Gunosewoyo, AP Montgomery, M Connor, M Kassiou
Tetrahedron letters 60 (36), 151019, 2019
52019
Strategies for targeting the P2Y12 receptor in the central nervous system
BB Ma, AP Montgomery, B Chen, M Kassiou, JJ Danon
Bioorganic & Medicinal Chemistry Letters 71, 128837, 2022
42022
Synthesis and biological evaluation of selective phosphonate-bearing 1, 2, 3-triazole-linked sialyltransferase inhibitors
C Dobie, AP Montgomery, R Szabo, H Yu, D Skropeta
RSC Medicinal Chemistry 12 (10), 1680-1689, 2021
42021
Synthesis and Preclinical Evaluation of Fluorinated 5-Azaindoles as CB2 PET Radioligands
A Kallinen, K Mardon, S Lane, AP Montgomery, R Bhalla, DHR Stimson, ...
ACS Chemical Neuroscience 14 (16), 2902-2921, 2023
22023
Understanding In Vitro Pathways to Drug Discovery for TDP-43 Proteinopathies
HWA Cheng, TB Callis, AP Montgomery, JJ Danon, WT Jorgensen, YD Ke, ...
International Journal of Molecular Sciences 23 (23), 14769, 2022
22022
Efficacy of DYRK1A inhibitors in novel models of Down syndrome acute lymphoblastic leukemia
SL Carey-Smith, MH Simad, K Panchal, C Aya-Bonilla, H Smolders, S Lin, ...
Haematologica, 2020
12020
Structure-Based Drug Design for TSPO: Challenges and Opportunities
M Giladi, AP Montgomery, M Kassiou, JJ Danon
Biochimie, 2024
2024
Synthesis of α‐Hydroxy‐1, 2, 3‐Triazole‐linked Sialyltransferase Inhibitors and Evaluation of Selectivity Towards ST3GAL1, ST6GAL1 and ST8SIA2
R Szabo, C Dobie, A Montgomery, H Steele, H Yu, D Skropeta
ChemMedChem, e202400088, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20